article_snippet: One of Australia's most popular pain killers has been left with a splitting headache, as the national consumer watchdog gets ready to take the national consumer watchdog to court.
article_snippet: Reckitt Benckiser, the company behind Nurofen in Australia, will square off against Australian Competition and Consumer Commission in federal court this month over claims that Australian Competition and Consumer Commission has mislead customers.
article_snippet: ACCC will dispute claims made by Reckitt Benckiser, the company behind Nurofen in Australia that the Nurofen Specific Pain Range is specially designed to target different types of pain.
article_snippet: the national consumer watchdog claims that all products contain identical ingredients.
article_snippet: Australia's consumer watchdog is taking Nurofen to court over Australia's consumer watchdog advertising claiming Australia's consumer watchdog products target  specific types of pain .
article_snippet: The products in question are: Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache.
article_snippet: In this case, we allege that consumers have been misled into purchasing Nurofen Specific Pain Products under the belief that each product is specifically designed for and effective in treating a particular type of pain, when this is not this case.'
article_snippet: ACCC also flagged the 'significantly' higher cost of Nurofen compared to other products as a concern, with the range in question costing up to twice as much as a standard pain killer sold by Nurofen or another comparable brand.
article_snippet: A Nurofen spokeswoman denied the allegations in a statement, and said pain-specific products made life easier for customers. '
article_snippet: Nurofen is committed to the quality use of medicines and promoting and protecting the health of Australians,' a statement read. '
article_snippet: Nurofen works closely with all regulatory bodies to ensure high standards compliance to guidelines. '
article_snippet: Nurofen will continue to work with regulators to ensure Nurofen packaging continues to be fully aligned with all guidelines and requirements and still offer consumers with clear pain relief options for consumers pain type.'
highlights_snippet: Alleges Nurofen claims 'misleading customers', all tablets exactly the same .
  
highlights_snippet: ACCC says all pills have the same key ingredient, ibuprofen lysine 342mg .
  